Systematic review of cardiovascular intervention studies in women after Preeclampsia

Jessica V Yao1, John Zhu2, Stacey Peters1

  • 1Department of Cardiology, The Royal Melbourne Hospital, Parkville, Victoria, Australia; Department of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, Victoria, Australia.

Pregnancy Hypertension
|March 12, 2026
PubMed

Insights

Preeclampsia (PE) increases later-life cardiovascular disease (CVD) risk. This review found exercise, multidisciplinary clinics, and home blood pressure monitoring may reduce this risk, but more research is needed for optimal prevention strategies.

Area of Science:

  • Cardiovascular Health
  • Obstetrics
  • Preventive Medicine

Background:

  • Preeclampsia (PE) affects 2-4% of pregnancies globally, causing significant morbidity and mortality.
  • PE is a known risk factor for developing cardiovascular disease (CVD) later in life.
  • Current guidelines acknowledge this risk but lack consensus on effective risk-reduction strategies for affected women.

Purpose of the Study:

  • To systematically review interventions aimed at reducing long-term CVD risk in women with a history of PE.
  • To assess the efficacy of various therapeutic approaches trialled in this high-risk population.

Main Methods:

  • A systematic literature search was conducted across MEDLINE, EMBASE, and CINAHL databases.
  • PRISMA guidelines were followed to identify relevant studies.
  • Included studies explored interventions for CVD risk reduction in women with a history of PE.

Main Results:

  • Eight studies involving 728 women were analyzed.
  • Interventions included exercise programs, web-based platforms, multidisciplinary team (MDT) clinics, and telemonitored home blood pressure (BP) monitoring.
  • Exercise improved fitness and vascular function. MDT clinics and home BP monitoring reduced CVD risk factors, while web-based interventions showed limited impact on risk factors.

Conclusions:

  • Reducing CVD risk in women with a history of PE presents challenges.
  • An optimal strategy may integrate early education, structured exercise, and digital platforms.
  • Larger studies are necessary to establish definitive CVD risk prevention strategies for this cohort.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
696
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
36.6K
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
494
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
505
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
359
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
574